Craig Gerrand, a consultant orthopaedic surgeon, carried out the first transplant of its kind on an unnamed man in his 60s. The patient, who had half his pelvis removed because of a rare cancer called chondrosarcoma, is now walking again with the aid of a stick. Mr Gerrand, who works at Newcastle upon Tyne Hospitals NHS Trust, said: The cancer affected virtually the whole right side of the pelvis. ‘Since this cancer does not respond to drugs or radiotherapy, the only option was to remove half of the pelvis. The surgeon said that so much bone had to be removed to stop the spread of cancer, he would have been unable to attach a standard implant made by hand. He said there was a chance the 3D print might not fit, or that it might fracture, but added that the patient was aware of the risks. It is widely believed that 3D printing has the capacity to revolutionise healthcare, with many medical applications for the procedure. Although still in its infancy, surgeons and scientists are already collaborating on innovations, with computer-controlled machines assembling biological matter using organic inks and super-tough thermoplastics. They range from reconstructing major sections of the skull to printing scaffolding upon which stem cells can grow into new bones. The GIF(T) of life: Amazing footage reveals how a human lung is kept alive and BREATHING for a transplant In the future, it is thought 3D printing may even be able to deliver new organs for transplant into patients on demand. For the pelvis operation, the surgical team used scans to measure the exact amount of bone that needed removing, and a replacement part was created on a 3D printer. The measurements were passed on to Stanmore Implants, which created the bespoke implant by fusing layers of titanium together using a laser, and coating it with a mineral into which the remaining bone cells could grow.
NTU medical school to research on healthcare needs of Singapore’s ageing population
Ramakrishnan has even defined some of the techniques that are used in fine breast reconstruction in the UK today. He has decided to spend more time every year in Chennai, the city where he grew up and studied medicine, giving back to the city the best of his skill and trade. I intend to come here every three months for two weeks at a stretch, and while I am here, I will work closely with the Chennai Breast Centre, and Selvi Radhakrishnan, oncoplastic breast surgeon. Dr. Selvi is among a rare breed of doctors who has entered a massively specialised field, he said. On offer soon, would be both removal of the breast and treatment for breast cancer, and reconstruction surgery. While reconstruction would be offered as a therapeutic tool post cancer surgery, and is likely to be sought after, removing and reconstructing the breast as a preventive measure is also possible, he said. However, he says it is important to keep preventive mastectomy in context. We must remember that only three percent of breast cancer is genetic. While the Jolie incident brought some spotlight on the cause, preventive mastectomy is not for all, he said. Micro reconstruction has not quite caught the imagination of the public in India, while in Britain, where a third of all plastic surgery work in the west is done, all mastectomy patients are offered breast reconstruction as an option by the National Health Service. It is mandatory for us to offer reconstruction.
UK doctor offers advanced breast cancer care
Get the full story from The Straits Times . Here is the press release from NTU in full: Nanyang Technological University (NTU) today unveiled the integrated research strategy of its Lee Kong Chian School of Medicine, aimed at addressing Singapore’s key health challenges. Jointly set up by NTU and Imperial College London, the School welcomed its first intake of 54 students in August last year. The medical school’s research strategy, which draws on NTU’s and Imperial’s excellent track record of reaping synergies between medicine, science and technology, comprises four themes: Infectious Disease, Metabolic Disease, Neuroscience and Mental Health, and Dermatology and Skin Biology. These four research themes are underpinned by the cross-cutting technology platforms in Developmental Biology, Structural Biology, Metabolomics and Sequencing Technologies, and Translational Imaging and Health Services Outcome Research. NTU President Professor Bertil Andersson today announced the school’s integrated research strategy and introduced influential world-class scientist and scientific leader Professor Philip Ingham FRS as the school’s Vice-Dean of Research. A Fellow of the Royal Society and the UK Academy of Medical Sciences, Professor Ingham is widely credited for his ground-breaking work in modelling human disease in the zebrafish. His research has provided fundamental insights into cell signalling in the developing embryo, in particular the Hedgehog signalling pathway, and has relevance both to regenerative medicine and cancer. Professor Bertil Andersson says, “NTU now has a formidable life sciences cluster, with the medical school, the School of Biological Sciences, the Singapore Centre on Environmental Life Sciences Engineering (SCELSE) and a new structural biology research centre headed by Professor Daniela Rhodes FRS, formerly from Cambridge University. Promising inter-disciplinary research between our new medical school and other NTU schools has already started. With Professor Philip Ingham FRS leading a team of global experts and a research strategy focused on Singapore needs, we can expect NTU’s research in healthcare to serve the population’s needs well into the future.” Having a medical school with a world-class research strategy will further boost NTU’s known strengths in biomedical engineering that has produced a number of breakthroughs and world’s firsts over the years, such as the world’s smallest piezoelectric heart pump in 2003 invented by NTU Provost, Professor Freddy Boey. His second invention in 2004 is a fully biodegradable coronary stent, co-developed with Professor Subbu Venkatraman from NTU, which has been successfully implanted in human patients. Another example of a world’s first from NTU is a pair of endoscopy robotic arms used for removing stomach tumours without surgery developed by NTU’s Associate Professor Louis Phee. Research with Singaporeans in mind The medical school has identified four research themes in which it could best achieve research excellence, against a backdrop of Singapore’s ageing population and an understanding of the healthcare needs of Singaporeans accustomed to a modern lifestyle. LKCMedicine Dean Professor Dermot Kelleher, who is also Dean of Imperial’s Faculty of Medicine, says, “We aim to elucidate the cellular and molecular basis of human diseases through innovative research programmes and to develop new therapies based on this understanding.” Metabolic disease Singapore’s ageing population brings with it key health challenges related to metabolic and cardiovascular disease which also impacts healthcare costs.